Covance Inc.  

(Public, NYSE:CVD)   Watch this stock  
Find more results for Watson Pharmaceuticals, Inc
+0.31 (0.39%)
Real-time:   2:02PM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 79.59 - 80.59
52 week 73.57 - 106.50
Open 79.92
Vol / Avg. 331,523.00/522,861.00
Mkt cap 4.46B
P/E 29.00
Div/yield     -
EPS 2.75
Shares 56.53M
Beta 0.89
Inst. own 94%
Nov 12, 2014
Covance Inc at Credit Suisse Healthcare Conference - 1:30PM EST - Add to calendar
Nov 4, 2014
Q3 2014 Covance Inc Earnings Call - 9:00AM EST - Add to calendar
Nov 3, 2014
Q3 2014 Covance Inc Earnings Release - 4:00PM EST - Add to calendar
Sep 16, 2014
Covance Inc at Credit Suisse Small & Mid Cap Conference
Sep 9, 2014
Covance Inc at Morgan Stanley Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 2.46% 6.91%
Operating margin 2.80% 8.37%
EBITD margin - 15.31%
Return on average assets 2.67% 7.40%
Return on average equity 4.15% 12.48%
Employees 12,501 -
CDP Score - -


210 Carnegie Center
United States - Map
+1-609-4524440 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Covance Inc. is a drug development services company providing a range of early-stage and late-stage product development services on a worldwide basis primarily to the pharmaceutical, biotechnology and medical device industries. The Company also provides laboratory testing services to the chemical, agrochemical and food industries. The services it provides constitutes two segments: early development services, which includes discovery support services, preclinical services and clinical pharmacology services, and late-stage development services, which includes central laboratory, Phase II-IV clinical development, and market access services. In September 2014, the Company acquired shares of Covance Antibody Services Inc., business unit of Covance, located in Dedham, Massachusetts.

Officers and directors

Joseph L. Herring Chairman of the Board, Chief Executive Officer
Age: 58
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Alison A. Cornell Chief Financial Officer, Vice President
Age: 51
Bio & Compensation  - Reuters
Richard F. Cimino Executive Vice President, Group President - Clinical Development
Age: 54
Bio & Compensation  - Reuters
Deborah L. Keller Tanner Executive Vice President, Group President - Research and Development Laboratories
Age: 51
Bio & Compensation  - Reuters
William E. Klitgaard Corporate Senior Vice President, Chief Information Officer
Age: 60
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
James W. Lovett Esq. Corporate Senior Vice President, General Counsel, Secretary
Age: 49
Bio & Compensation  - Reuters
John E. Watson Corporate Senior Vice President, Chief Commercial Officer, President - Strategic Partnering
Age: 54
Bio & Compensation  - Reuters
Brian H. Nutt Principal Accounting Officer, Senior Director of External Reporting
Age: 44
Bio & Compensation  - Reuters
Gary E. Costley Ph.D. Lead Independent Director
Age: 70
Bio & Compensation  - Reuters
Robert L. Barchi M.D., Ph.D. Independent Director
Age: 67
Bio & Compensation  - Reuters